Show simple item record

dc.creatorNiu, Xiaoling
dc.creatorRoche, Lisa M
dc.creatorPawlish, Karen S
dc.creatorHenry, Kevin A
dc.date.accessioned2021-01-31T19:09:47Z
dc.date.available2021-01-31T19:09:47Z
dc.date.issued2013-06
dc.identifier.issn2045-7634
dc.identifier.issn2045-7634
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/5383
dc.identifier.otherV36KJ (isidoc)
dc.identifier.other23930216 (pubmed)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/5401
dc.description.abstractPrevious studies found that uninsured and Medicaid insured cancer patients have poorer outcomes than cancer patients with private insurance. We examined the association between health insurance status and survival of New Jersey patients 18-64 diagnosed with seven common cancers during 1999-2004. Hazard ratios (HRs) with 95% confidence intervals for 5-year cause-specific survival were calculated from Cox proportional hazards regression models; health insurance status was the primary predictor with adjustment for other significant factors in univariate chi-square or Kaplan-Meier survival log-rank tests. Two diagnosis periods by health insurance status were compared using Kaplan-Meier survival log-rank tests. For breast, colorectal, lung, non-Hodgkin lymphoma (NHL), and prostate cancer, uninsured and Medicaid insured patients had significantly higher risks of death than privately insured patients. For bladder cancer, uninsured patients had a significantly higher risk of death than privately insured patients. Survival improved between the two diagnosis periods for privately insured patients with breast, colorectal, or lung cancer and NHL, for Medicaid insured patients with NHL, and not at all for uninsured patients. Survival from cancer appears to be related to a complex set of demographic and clinical factors of which insurance status is a part. While ensuring that everyone has adequate health insurance is an important step, additional measures must be taken to address cancer survival disparities.
dc.format.extent403-411
dc.language.isoen
dc.relation.haspartCANCER MEDICINE
dc.relation.isreferencedbyWiley
dc.rightsCC BY
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.subjectBladder cancer
dc.subjectbreast cancer
dc.subjectcervical cancer
dc.subjectcolorectal cancer
dc.subjectdisparities
dc.subjectinsurance status
dc.subjectlung cancer
dc.subjectnon-Hodgkin lymphoma
dc.subjectprostate cancer
dc.subjectsurvival
dc.titleCancer survival disparities by health insurance status
dc.typeArticle
dc.type.genreJournal Article
dc.type.genreResearch Support, N.I.H., Extramural
dc.type.genreResearch Support, Non-U.S. Gov't
dc.type.genreResearch Support, U.S. Gov't, P.H.S.
dc.relation.doi10.1002/cam4.84
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.date.updated2021-01-31T19:09:44Z
refterms.dateFOA2021-01-31T19:09:47Z


Files in this item

Thumbnail
Name:
Cancer survival disparities by ...
Size:
597.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

CC BY
Except where otherwise noted, this item's license is described as CC BY